Purchase Order HHSD2002016M90048P
Award Date 5/31/16
Potential Completion Date 6/4/17
Potential Value $32K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Everettville, WV 26505, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Heart Lung and Blood Institute issued a purchase order to Georgetown University on July 24, 2017, for an Agilent Mouse Gene Expression V2 4x44K microarray (Catalog G4846A) valued at $4,050.00 under firm fixed pricing. Work is performed in Washington, DC 20057. The order is not set-aside and carries an ultimate completion date of August 31, 2017.</p>
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $996,710 firm fixed price purchase order to Lumicks USA Inc. to generate HBB, HBBS, and HBBE knock-in mice. The solicitation sought a contractor capable of generating transgenic and knock-in mouse models using CRISPR/Cas9 or other genome editing technologies for biomedical research purposes. No set-aside designation or incumbent contractor was specified. Lumicks will...
- <p>The National Heart Lung and Blood Institute issued a purchase order to Moore, Mark Wade for $64,497.28 on June 28, 2017, for Phase 2 Knock-Out Mouse Phenotyping (KOMP2) project support. The work provides specialized knowledge and expertise in immunology, antigen and gene technology for the NHGRI International Mouse Phenotyping Consortium. Performance takes place in Bethesda, Maryland, with a completion date of October 31, 2017.</p>
- <p>The National Heart, Lung and Blood Institute awarded a purchase order to Psomagen Inc. for $48,777.00 on May 14, 2026, for Olink Explore HT proteomic analysis supporting a sepsis biomarker study. Work is performed in Rockville, Maryland. The order is firm fixed price with no set-aside designation and completes by November 21, 2026. Performance is severable.</p>
- The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, has awarded a $171,374 firm fixed price purchase order to Lovelace Biomedical Research Institute. Under this contract, Lovelace will conduct an evaluation of an angiotensin-converting enzyme inhibitor in a mouse model combining cigarette smoke exposure and influenza infection. All work will be performed by Lovelace in Albuquerque, New Mexico over a one-year...
- This firm fixed price delivery order for $24,990 was awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute. The order was issued against the GSA Schedule for Professional and Allied Healthcare Staffing Services and requires a mouse study of smoking to further the research aims of the Levy Lab at NIH/NHBLI/PSB regarding developing therapeutic targets. The study is to be completed by...
- This federal contract award was made by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the Medical College of Wisconsin Inc. for "OTHER FUNCTIONS - R & D, NATIONAL HEART, LUNG, AND BLOOD INSTITUTE PROTEOMICS INITIATIVE." The $2,358,930.83 definitive contract has a cost-no-fee pricing type and was awarded on September 15, 2002, with a final completion date of June 30, 2010. The contract does not have a set-aside designation. The award is not...
- The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...
- This is a $30,000.00 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to MS Bioworks LLC, a for-profit limited liability company located in Ann Arbor, Michigan. The contract is for pulmonary tissue analysis services, which aligns with the CDC's mission in public health monitoring and biomedical research. The contract does not have a set-aside designation. MS Bioworks, which is registered in the System for Award Management (SAM) and has...
- This is a federal contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit research organization. The award is for the development of a murine (mouse) model of pulmonary chlorine exposure, with a ceiling value of $1,047,135.50 and a period of performance ending on September 30, 2020. The contract is a cost-plus-fixed-fee type, without any set-aside...
COMPARATIVE PROTEOMICS ON MOUSE LUNGS STUDY.
Posted 6/1/16
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Profiling and Analysis of Whole Proteome | 2016-Q-65191 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Award Notice 1/1 | 5/24/16, 7:06 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.0k | 6/1/16 |